Nitrous oxide does not depress left ventricular contractility in ischemic rat heart

Area of Science:

• Cardiology
• Anesthesiology
• Physiology

Background:

• Myocardial oxygen consumption (MVO2) and contractility are critical indicators of heart function, especially during ischemia.
• Nitrous oxide is a common anesthetic agent whose direct cardiac effects require thorough investigation.

Purpose of the Study:

• To investigate the direct impact of nitrous oxide on left ventricular contractility and MVO2 in an isolated, globally ischemic rat heart model.
• To compare the effects of nitrous oxide with nitrogen and halothane under ischemic conditions.

Main Methods:

• Isolated rat hearts were perfused using the Langendorf technique.
• Left ventricular pressures and dP/dt were measured using an intraventricular balloon.
• Myocardial oxygen consumption (MVO2) was calculated, and coronary flow was monitored.
• Hearts were subjected to global ischemia by reducing perfusion pressure, followed by a reperfusion phase.

Main Results:

• Nitrous oxide did not significantly alter myocardial contractility or MVO2 compared to nitrogen during the ischemic phase.
• Halothane significantly reduced left ventricular contractility and MVO2 during ischemia compared to the control group.
• Nitrous oxide did not exacerbate the negative effects of ischemia on cardiac function beyond those caused by nitrogen.

Conclusions:

• Nitrous oxide exhibits a neutral effect on myocardial contractility and MVO2 in the ischemic isolated rat heart, unlike halothane.
• These findings suggest that nitrous oxide may be a safer anesthetic option in ischemic cardiac conditions compared to halothane, based on direct myocardial effects.